Abstract
Leukemias are often driven by the expression of leukemic-specific fusion genes. Exclusive targeting of these fusion genes using RNA interference is therefore an attractive therapeutic concept. Lipid nanoparticles (LNPs) have evolved rapidly as promising delivery systems for oligonucleotides, including siRNAs. Current approaches, however, show high liver accumulation after systemic administration
... read more